Blood test could help some rectal cancer patients avoid surgery
NCT ID NCT07209215
Summary
This study is testing whether a sensitive blood test can help doctors decide the best next step for patients with early-stage rectal cancer who have completed initial chemotherapy and radiation. The test looks for tiny bits of cancer DNA in the blood. Based on the test result, patients will either have standard surgery or enter a careful monitoring program to see if surgery can be safely avoided.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.